Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients an...

Full description

Bibliographic Details
Main Authors: Andriana I Papaioannou, Konstantinos Kostikas, Effrosyni D Manali, Georgia Papadaki, Aneza Roussou, Aris Spathis, Argyro Mazioti, Ioannis Tomos, Ilias Papanikolaou, Stelios Loukides, Kyriakos Chainis, Petros Karakitsos, Matthias Griese, Spyros Papiris
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4919090?pdf=render
_version_ 1828762276503486464
author Andriana I Papaioannou
Konstantinos Kostikas
Effrosyni D Manali
Georgia Papadaki
Aneza Roussou
Aris Spathis
Argyro Mazioti
Ioannis Tomos
Ilias Papanikolaou
Stelios Loukides
Kyriakos Chainis
Petros Karakitsos
Matthias Griese
Spyros Papiris
author_facet Andriana I Papaioannou
Konstantinos Kostikas
Effrosyni D Manali
Georgia Papadaki
Aneza Roussou
Aris Spathis
Argyro Mazioti
Ioannis Tomos
Ilias Papanikolaou
Stelios Loukides
Kyriakos Chainis
Petros Karakitsos
Matthias Griese
Spyros Papiris
author_sort Andriana I Papaioannou
collection DOAJ
description Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival.122 consecutive patients (31 emphysema, 62 IPF, and 29 CPFE) and 25 healthy controls underwent PFTs, ABG-measurements, 6MWT and chest HRCT. Serum levels of SPs were measured. Patients were followed-up for 1-year.SP-A and SP-D levels differed between groups (p = 0.006 and p<0.001 respectively). In post-hoc analysis, SP-A levels differed only between controls and CPFE (p<0.05) and CPFE and emphysema (p<0.05). SP-D differed between controls and IPF or CPFE (p<0.001 for both comparisons). In IPF SP-B correlated to pulmonary function while SP-A, correlated to the Composite Physiological Index (CPI). Controls current smokers had higher SP-A and SP-D levels compared to non-smokers (p = 0.026 and p = 0.023 respectively). SP-D levels were higher in CPFE patients with extended emphysema (p = 0.042). In patients with IPF, SP-B levels at the upper quartile of its range (≥26 ng/mL) presented a weak association with reduced survival (p = 0.05).In conclusion, serum SP-A and SP-D levels were higher where fibrosis exists or coexists and related to disease severity, suggesting that serum SPs relate to alveolar damage in fibrotic lungs and may reflect either local overproduction or overleakage. The weak association between high levels of SP-B and survival needs further validation in clinical trials.
first_indexed 2024-12-11T01:42:03Z
format Article
id doaj.art-0d042095c9fd458894328cc63c172723
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T01:42:03Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-0d042095c9fd458894328cc63c1727232022-12-22T01:25:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015778910.1371/journal.pone.0157789Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).Andriana I PapaioannouKonstantinos KostikasEffrosyni D ManaliGeorgia PapadakiAneza RoussouAris SpathisArgyro MaziotiIoannis TomosIlias PapanikolaouStelios LoukidesKyriakos ChainisPetros KarakitsosMatthias GrieseSpyros PapirisEmphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage. We evaluated serum SP levels in healthy controls, emphysema, IPF, and CPFE patients and their associations to disease severity and survival.122 consecutive patients (31 emphysema, 62 IPF, and 29 CPFE) and 25 healthy controls underwent PFTs, ABG-measurements, 6MWT and chest HRCT. Serum levels of SPs were measured. Patients were followed-up for 1-year.SP-A and SP-D levels differed between groups (p = 0.006 and p<0.001 respectively). In post-hoc analysis, SP-A levels differed only between controls and CPFE (p<0.05) and CPFE and emphysema (p<0.05). SP-D differed between controls and IPF or CPFE (p<0.001 for both comparisons). In IPF SP-B correlated to pulmonary function while SP-A, correlated to the Composite Physiological Index (CPI). Controls current smokers had higher SP-A and SP-D levels compared to non-smokers (p = 0.026 and p = 0.023 respectively). SP-D levels were higher in CPFE patients with extended emphysema (p = 0.042). In patients with IPF, SP-B levels at the upper quartile of its range (≥26 ng/mL) presented a weak association with reduced survival (p = 0.05).In conclusion, serum SP-A and SP-D levels were higher where fibrosis exists or coexists and related to disease severity, suggesting that serum SPs relate to alveolar damage in fibrotic lungs and may reflect either local overproduction or overleakage. The weak association between high levels of SP-B and survival needs further validation in clinical trials.http://europepmc.org/articles/PMC4919090?pdf=render
spellingShingle Andriana I Papaioannou
Konstantinos Kostikas
Effrosyni D Manali
Georgia Papadaki
Aneza Roussou
Aris Spathis
Argyro Mazioti
Ioannis Tomos
Ilias Papanikolaou
Stelios Loukides
Kyriakos Chainis
Petros Karakitsos
Matthias Griese
Spyros Papiris
Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
PLoS ONE
title Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
title_full Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
title_fullStr Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
title_full_unstemmed Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
title_short Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).
title_sort serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema cpfe
url http://europepmc.org/articles/PMC4919090?pdf=render
work_keys_str_mv AT andrianaipapaioannou serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT konstantinoskostikas serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT effrosynidmanali serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT georgiapapadaki serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT anezaroussou serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT arisspathis serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT argyromazioti serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT ioannistomos serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT iliaspapanikolaou serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT steliosloukides serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT kyriakoschainis serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT petroskarakitsos serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT matthiasgriese serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe
AT spyrospapiris serumlevelsofsurfactantproteinsinpatientswithcombinedpulmonaryfibrosisandemphysemacpfe